• Nie Znaleziono Wyników

Percutaneous retrograde paramitral leak closure through a mechanical aortic valve

N/A
N/A
Protected

Academic year: 2022

Share "Percutaneous retrograde paramitral leak closure through a mechanical aortic valve"

Copied!
2
0
0

Pełen tekst

(1)

KARDIOLOGIA POLSKA 2019; 77 (4) 482

Plug III (10 × 5 mm) was selected, introduced through the delivery sheath (FIGURE 1C), and de‑

ployed. Once the correct implant position and stability, as well as leak reduction, was confirmed by TEE (mild para‑device regurgitation; Sup‑

plementary material, Figure S1, Panel B1–B3), the plug was released (FIGURE 1D). The postproce‑

dural course was uneventful. During 18 months of follow‑up, the patient’s exercise tolerance in‑

creased significantly. Control transthoracic echo‑

cardiography demonstrated a mild residual leak.

Percutaneous paravalvular regurgitation clo‑

sure can be performed using an anterograde transseptal, retrograde transapical, or retro‑

grade transaortic approach. The closure of me‑

dially located leaks anterogradely is challeng‑

ing without a steerable sheath. Furthermore, a transseptal puncture may be difficult in pre‑

viously operated patients with a potentially thickened or calcified septum. The transapical approach ensures a direct access to parasep‑

tal defects; however, it may result in postoper‑

ative bleeding and hemothorax in up to 19% of patients.3

The retrograde transaortic approach is suit‑

able for medially located defects, but in patients with mechanical aortic valve prosthesis, it must be performed with caution owing to the risk of obstruction. Unsuccessful attempts with he‑

modynamic deterioration have been report‑

ed.4 A successful retrograde procedure through a mechanical prosthesis has also been described, but in a different clinical setting, namely, in 2 older patients with preserved ejection frac‑

tion, less severe heart failure symptoms, and lateral leak location.5

Paravalvular regurgitation is present in up to 17% of patients undergoing valve replacement surgery.1 The preferred treatment of choice is surgical reintervention; however, the percuta‑

neous approach is a valid alternative in symp‑

tomatic patients at high surgical risk.2

A 24‑year‑old man with a history of aortic valve replacement with a mechanical bileaflet prosthesis (29 mm), mitral valve annuloplasty (32 mm), and tricuspid annuloplasty (de Vega type) was admitted due to heart failure symp‑

toms. An index surgery for acute heart failure with severe valvular dysfunction was performed 2 months earlier; an underlying connective tis‑

sue disorder was suspected. Transthoracic echo‑

cardiography demonstrated global hypokinesis of the left ventricle with an ejection fraction of 26%. Transesophageal echocardiography (2‑

and 3‑dimensional) revealed significant mitral regurgitation due to periannular anterior mi‑

tral leaflet perforation by a surgical suture (ef‑

fective regurgitation orifice, 0.47 cm2; regurgi‑

tant volume, 51 ml) (Supplementary material, Figure S1, Panel A1–A3).

Owing to high risk of redo surgery and the me‑

dial location of the leak, the patient was referred for a percutaneous procedure via a retrograde transaortic approach. The procedure was per‑

formed under general anesthesia under 2‑ and 3‑dimensional TEE guidance. Using a hydrophil‑

ic guidewire and an extra back‑up guiding cath‑

eter, the defect was crossed and the guidewire was secured in the left upper pulmonary vein (FIGURE 1A). Next, a delivery sheath was inserted (FIGURE 1B), whose presence across the mechanical aortic prosthesis resulted in a temporary move‑

ment obstruction of one of the discs, although without a significant blood pressure drop. Based on 3‑dimensional TEE, an Amplatzer Vascular

Correspondence to:

Karol Zbroński, MD,  1st Department of Cardiology,  Medical University of Warsaw,  ul. Banacha 1a, 02-097 Warszawa,  Poland, phone: +48 22 599 19 58,  email: karol.zbronski@gmail.com Received: December 12, 2018.

Revision accepted:

February 15, 2019.

Published online:  April 25, 2019.

Kardiol Pol. 2019; 77 (4): 482-483 doi:10.33963/KP.14799 Copyright by Polskie Towarzystwo  Kardiologiczne, Warszawa 2019

C L I N I C A L V I G N E T T E

Percutaneous retrograde paramitral leak closure through a mechanical aortic valve

Karol Zbroński1, Robert Sabiniewicz2, Piotr Scisło1, Anna Siennicka1, Janusz Kochman1, Zenon Huczek1 1  1st Department of Cardiology, Medical University of Warsaw, Warsaw, Poland

2  Department of Pediatric Cardiology and Congenital Heart Diseases, Medical University of Gdańsk, Gdańsk, Poland

(2)

C L I N I C A L V I G N E T T E Retrograde paramitral leak closure through a mechanical valve 483 SUPPLEMENTARY MATERIAL

Supplementary material is available at www.mp.pl/kardiologiapolska.

ARTICLE INFORMATION

CONFLICT OF INTEREST None declared.

HOW TO CITE Zbroński K, Sabiniewicz R, Scisło P, et al. Percutaneous retro- grade paramitral leak closure through a mechanical aortic valve. Kardiol Pol. 2019; 

77: 482-483. doi:10.33963/KP.14799

REFERENCES

1  Rihal CS, Sorajja P, Booker JD, et al. Principles of percutaneous paravalvular  leak closure. JACC Cardiovasc Interv. 2012; 5: 121-130.

2  Nishimura  RA,  Otto  CM,  Bonow  RO,  et  al.  2014  AHA/ACC  guidelines  for  the management of patients with valvular heart disease. J Am Coll Cardiol. 2014; 

63: 2438-2488.

3  Pitta SR, Cabalka AK. Complications associated with left ventricular puncture. 

Catheter Cardiovasc Interv. 2010; 76: 993-997.

4  Larman M, Lasa G, Sanmartín JC, Gaviria K. Transapical technique as an al- ternative approach to paravalvular leak closure. Rev Esp Cardiol. 2011; 64: 80-82.

5  Zhou D, Pan W, Guan L, et al. Retrograde transcatheter closure of mitral para- valvular leak through a mechanical aortic valve prosthesis: 2 successful cases. Tex  Heart Inst J. 2016; 43: 137-141.

D C

A B

FIGURE 1

A – a guidewire crossing the mechanical aortic valve and the paramitral leak secured in the left upper pulmonary vein (arrow);

B – a delivery sheath crossing the mechanical aortic valve and

the paramitral leak secured in the right lower pulmonary vein (arrow);

C – partial deployment of the device in the left atrium (arrow); D – final effect with the device fully deployed and released (arrow)

Cytaty

Powiązane dokumenty

ence of >48° angle between the aortic annulus Transcatheter aortic valve implantation (TAVI)4. is a well ‑established modern treatment of severe symptomatic

dergoing aortic valve repair (BAV > TAV) suggests that many patients with AI are still considered for aortic valve repair, except for young patients with a congenital BAV.

Compared to conventional aortic valve replacement (con-AVR, sternotomy), minimally invasive aortic valve replacement (mini-AVR) is associated with lower morbidity and mortality

One year later the patient was admitted again due to a false aneurysm at the region of proximal anastomosis of supracoronary graft and persistent dissection of aortic arch

Feasibility and outcomes of transcatheter aortic valve implantation in high-risk patients with stenotic bicuspid aortic valves.. Zegdi R, Khabbaz Z, Ciobotaru V

Computed tomography angiography confirmed aortic dissection — Stanford type A, with dissected aortic arch, brachiocephalic trunk, both common carotid arteries, and the left

Conclusions: This early clinical experience using an aortic bioprosthetic valve treated with a novel anti-calcification tissue processing technology demonstrated excellent

Transcatheter aortic valve replacement (TAVR) has proven to be a valuable alternative to conventional surgical aortic valve replacement in high risk and surgically inoperable